Viewing Study NCT03000257


Ignite Creation Date: 2025-12-24 @ 7:02 PM
Ignite Modification Date: 2026-02-23 @ 8:33 AM
Study NCT ID: NCT03000257
Status: COMPLETED
Last Update Posted: 2022-04-14
First Post: 2016-12-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Budigalimab (ABBV-181) in Participants With Advanced Solid Tumors
Sponsor: AbbVie
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module